Pluristem Therapeutics Inc (NASDAQ:PSTI)

Data as of Sep 22
 -0.07 / -2.38%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Pluristem Therapeutics, Inc. is a bio-therapeutic company, which develops standardized cell therapy products for the treatment of life threatening diseases. The company's patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a variety of local and systemic inflammatory diseases. It offers to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders. Pluristem Therapeutics develops pipeline of products derived from human placenta, a non-controversial, non-embryonic, adult stem cell source. It intends to commercialize cell therapy production technologies and products. The company operates in Israel and United States of America. Pluristem Therapeutics was founded on May 11, 2001 and is headquartered in Haifa, Israel.

Contact Information

Pluristem Therapeutics, Inc.
MATAM Advanced Technology Park
Haifa Haifa 31905
Investor Relations:



Individual stakeholders7.48%
Mutual fund holders2.57%
Other institutional1.35%

Top Executives

Zami AbermanChairman & Chief Executive Officer
Yaky YanayPresident & Chief Operating Officer
Boaz Gur-LavieChief Financial Officer & Secretary
Racheli OfirVice President-Research & Intellectual Property
Esther Lukasiewicz-HagaiVice President-Clinical & Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.